A further demonstration of the clinical relevance of the p53 mutants and PI3K/AKT axis was provided by IHC staining of primary human breast cancers showing a positive correlation between high expression of p53 (an indicator of the presence of gain-of-function mutant p53) and strong phospho-AKT staining. Here, AKT1 is linked to breast cancer.